Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial

Cooney, Laura G.; Milman, L.W.; Hantsoo, Liisa; Kornfield, Sara L.; Sammel, Mary D.; Allison, Kelly C.; Epperson, C. Neill; Dokras, Anuja

doi:10.1016/j.fertnstert.2018.03.028

Cited by 72 publications

(91 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[15] Cooney et al found that 59% of participants who participated in cognitive behavioral therapy in addition to lifestyle counseling met exercise goals compared to 38% in the lifestyle counseling only group. [17] Ladson et al reported the • The PRT group reported a significant increase in body weight and BMI compared to the control group. There was also a significant reduction in waist circumference (p = 0.03) and a significant increase in lean mass (p = 0.01) and fat-free mass (p = 0.005), indicating that the weight gain was due to muscle hypertrophy, PRT group reported a significant reduction in HbA1c over time compared to the control group.…”

Section: Limitations Of Reported Adherence Datamentioning

confidence: 98%

“…All studies that reported adherence in any way were included. Logs of physical activity and/or diet, [16][17][18]20,22,24,27] self-reported recall, [15,18,20,21,23,24,26,28] and pill counts [14,15,19] were the most common methods to measure adherence. Twelve out of the 14 studies utilized self-reported data to measure adherence.…”

Section: Limitations Of Reported Adherence Datamentioning

confidence: 99%

“…Nine studies included a dietary intervention. [15][16][17][18][19][20]22,25,26] Dietary interventions studied included low calorie diets, a vegan diet, the DASH diet, and a soy-based diet. Adherence rates ranged from 86% reporting they made health-conscious dietary decisions [15] to 50% attending all of the required diet clinic meetings, [16] to 67% reporting they had accessed the dietary guidance materials.…”

Section: Limitations Of Reported Adherence Datamentioning

confidence: 99%

“…[26] Seven studies reported physical activity interventions. [15,17,19,22,24,25,27] Adherence to physical activity ranged widely depending on the type of intervention. For example, Vizza et al reported that adherence to supervised training was 76% compared with 43% for independent home-based exercise.…”

Section: Limitations Of Reported Adherence Datamentioning

confidence: 99%

See 3 more Smart Citations

Adherence to treatment for polycystic ovarian syndrome: A systematic review

Parker¹,

Warren²,

Nair³

et al. 2020

PLoS ONE

View full text Add to dashboard Cite

Background Polycystic ovarian syndrome (PCOS) is one of the most prevalent endocrine disorders of women of reproductive age. Treatment plans for this chronic condition frequently include long-term use of a combination of medication and lifestyle interventions. However, treatment outcomes are dependent on adherence to treatment regimens. This study aimed to systematically review the literature for reported adherence to treatments for PCOS. Methods A systematic search of Embase, Cochrane, PubMed, CINAHL, PsychINFO, SCOPUS, and International Pharmaceutical Abstracts from inception until January 2019 utilizing the terms PCOS, adherence, and patient compliance was conducted. A total of 179 possible articles were identified. Results Fourteen articles reporting adherence data were included in the review. Self-report was the most commonly reported method of measuring adherence. Adherence to lifestyle interventions, such as prescribed diets and physical activity, was reported in ten studies and adherence to medications was reported in seven studies, with some reporting both. Conclusions Minimal data are available regarding factors associated with adherence in patients with PCOS. Diverse methods of adherence assessment are utilized. Future studies of PCOS treatments should effectively assess and report adherence data as it is essential to evaluating the effectiveness of PCOS treatments and is critically needed to guide clinician efforts to facilitate optimal outcomes for patients.

show abstract

Section: Limitations Of Reported Adherence Datamentioning

confidence: 98%

Section: Limitations Of Reported Adherence Datamentioning

confidence: 99%

Section: Limitations Of Reported Adherence Datamentioning

confidence: 99%

Section: Limitations Of Reported Adherence Datamentioning

confidence: 99%

See 2 more Smart Citations

Adherence to treatment for polycystic ovarian syndrome: A systematic review

Parker¹,

Warren²,

Nair³

et al. 2020

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…In judging the curative efficacy, prolonged survival does not always mean improved health outcomes ( 16 ). Nowadays, the importance of health outcomes, equivalent to the remission rate and survival time, is increasingly attracting attention and has been regarded as an outcome indicator in cancer research ( 17 , 18 ). In order to understand the impact of the FOLFIRI and mFOLFOX6 regimens on the health outcomes of cancer patients, in this study, these two chemotherapy regimens were evaluated and compared, for the first time to our best knowledge, among different solid tumor patients after adjusting the impact of relevant factors such as disease.…”

Section: Introductionmentioning

confidence: 99%

Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients

Zhao

Hong

et al. 2020

Front. Oncol.

View full text Add to dashboard Cite

Fluorouracil combined with oxaliplatin (FOLFOX) and fluorouracil combined with irinotecan (FOLFIRI) are both first-line clinical chemotherapy regimens. However, clinicians' selection of FOLFIRI or FOLFOX medication regimens and their effects on patients' health outcomes are not clear. The aim of this study was to evaluate the impacts on patient characteristics of FOLFIRI or FOLFOX medication regimen selection and the effects of each regimen on patients' health outcomes in a real-world setting. Three thousand seven hundred and twenty-five patients were retrieved and 610 of them were eventually included in this study based on the inclusion and exclusion criteria. The percentages of the TNM stage, cetuximab, bevacizumab, and tumor metastases between the FOLFIRI and FOLFOX groups were different ( P < 0.001). In the multivariate Cox proportional hazards model, a significantly higher non-convalescent incidence of the FOLFOX group was found as compared with the FOLFIRI group (HR = 2.211, 95% CI = 1.257–3.888, P = 0.006). In conclusion, the TNM stage, whether combined with cetuximab or bevacizumab, and whether there was tumor metastasis presented as the key factors affecting medication selection between the FOLFIRI and FOLFOX regimens. The FOLFIRI regimen exhibited better effects on patients' long-term health outcomes than did the FOLFOX regimen. This study was registered on the World Health Organization International Clinical Trials Registry Platform (ChiCTR2000029201). Trial registration: ChiCTR2000029201.

show abstract

Cognitive behavioural therapy for women with infertility: A systematic review and meta‐analysis

Wang

Liu

2022

Clin Psychology and Psychoth

View full text Add to dashboard Cite

Cognitive behavioural therapy (CBT) has been used for women with infertility. However, the efficacy of CBT among the infertile female population remains inconclusive. We performed a systematic literature search using the Cochrane Library, MEDLINE (OVID), EMBASE (OVID), CINAHL, PsycINFO (OVID), Web of Science, and ProQuest databases from the inception to May 2022. The Cochrane risk of bias tool for randomized trials was used to assess the methodological quality of the included studies. Revman 5.4 was conducted for statistical analysis, and meta‐analyses were performed to calculate the pooled effects of CBT. Sixteen articles were finally included in the meta‐analysis. The results of the meta‐analysis revealed large, significant effects of cognitive‐behavioural interventions that can effectively reduce depression, anxiety symptoms, psychological distress, perceived stress, infertility‐specific stress, and improve the quality of life in women with infertility. However, the pooled MD using a fixed‐effects model was 0.25, 95% CI [−0.33, 0.84], P = 0.40, and no significant differences in BMI were observed among those who received CBT therapy compared with those who did not. CBT effectively alleviates depression, anxiety, psychological distress, and infertility‐specific stress levels and improves the quality of life among women with infertility. Future studies should explore the sustainability and long‐term effect of cognitive‐behavioural interventions in women with infertility.

show abstract

Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial

Abstract: NCT01899001.

Cited by 72 publications

References 56 publications

Adherence to treatment for polycystic ovarian syndrome: A systematic review

Adherence to treatment for polycystic ovarian syndrome: A systematic review

Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients

Cognitive behavioural therapy for women with infertility: A systematic review and meta‐analysis

Contact Info

Product

Resources

About